2021 PKD Regulatory Summit: ADPKD Protocol
Listen to Frank Czerwiec from Goldfinch Bio and Ronald Perrone from Tufts Medical Center present for the 2021 PKD Regulatory Summit. On May 19-20, 2021, the Critical Path Institute’s Polycystic Kidney Disease Outcomes Consortium (PKDOC) and The PKD Foundation invite you to participate in the 2021 PKD Regulatory Summit. Together with key stakeholders from the pharmaceutical industry, academic researchers, foundations, patient advocacy groups, individuals living with PKD, and regulatory agencies from around the world, we will address current unmet drug development needs for PKD, identify tools that are needed to deliver new therapies to patients, and catalyze the development of a regulatory framework to enable advancement of new treatments. The Summit includes a series of three sessions with pre-recorded webinars available for registrants to view at their own pace two weeks prior to the meeting. On May 19 and 20, live presentations will summarize content from the pre-recorded webinars and be followed by panel discussions with speakers to facilitate dialogue among all participants. Subscribe to C-Path Now ►► https://www.youtube.com/c/CriticalPathInstitute FOLLOW C-PATH: LinkedIn: https://www.linkedin.com/company/c-path Facebook: https://www.facebook.com/CPathInstitute/ Twitter: https://twitter.com/CPathInstitute?re ABOUT C-PATH: Critical Path Institute (C-Path) is an independent, nonprofit organization established in 2005 as a public and private partnership. C-Path’s mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. An international leader in forming collaborations, C-Path has established numerous global consortia that currently include more than 1,600 scientists from government and regulatory agencies, academia, patient organizations, disease foundations, and dozens of pharmaceutical and biotech companies. C-Path US is headquartered in Tucson, Arizona and C-Path, Ltd. EU is headquartered in Dublin, Ireland, with additional staff in multiple other locations. For more information, visit c-path.org and c-path.eu. #CPath #datasharing #nonprofit #drugdevelopment #ADPKD
Suggested videos

The Critical Path Institute Podcast: Advancing Drug Development on a Global Scale
Critical Path Institute · 33:30

2021 PKD Regulatory Summit: Translational Strategies for ADPKD
Critical Path Institute · 33:27

Who is Critical Path Institute?
Critical Path Institute · 0:46

2021 PKD Regulatory Summit: Assessing rapid progression in ADPKD
Critical Path Institute · 42:38

The Critical Path Institute Podcast: Advancing Neuromuscular Drug Development Through Collaboration
Critical Path Institute · 40:11

2021 PKD Regulatory Summit: Advancing the research of pediatric ADPKD
Critical Path Institute · 26:36

The Critical Path Institute Podcast: How C-Path's Accelerator Is Impacting Tomorrow's Medicines
Critical Path Institute · 31:11

2021 PKD Regulatory Summit: ADPKD: Diagnosis, Clinical Course, and health complications
Critical Path Institute · 43:57

The Critical Path Institute Podcast: Accelerating Drug Development in Friedreich's Ataxia
Critical Path Institute · 30:36

2021 PKD Regulatory Summit - Day 1
Critical Path Institute · 3:36:48

The Power of Lived Experience: Jessica Morris on ALS Research | CGIC 2026
Critical Path Institute · 2:28

2021 PKD Regulatory Summit: ARPKD: Clinical course, trial endpoints, and imaging
Critical Path Institute · 41:34